Experience of the use of lock therapy in pediatric patients with central venous catheter

被引:1
|
作者
Nino-Serna, Laura Fernanda [1 ]
Munoz, Catalina Mesa [1 ]
Copete, Diana [1 ]
Trujilloa, Monica [1 ,3 ]
Restrepo, Andrea [1 ]
Garces, Carlos [2 ]
机构
[1] Hosp Pablo Tobon Uribe, Medellin, Colombia
[2] Univ Antioquia, Clin Amer, Clin CardioVID, Medellin, Colombia
[3] Clin Univ Bolivariana, Univ CES, Medellin, Colombia
来源
ANDES PEDIATRICA | 2023年 / 94卷 / 03期
关键词
Lock Therapy; Bacteremia; Catheter-Related Infection; Central Venous Catheter; Pediatrics; Hematologic Neoplasms; BLOOD-STREAM INFECTIONS; HEMODIALYSIS; PREVENTION; GUIDELINES; MANAGEMENT; SOCIETY;
D O I
10.32641/andespediatr.v94i3.4458
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Lock therapy is useful for preserving indwelling catheters. Few lock therapy studies have been publis-hed in Latin America. Objective: To describe the clinical characteristics of pediatric patients using therapeutic and prophylactic lock therapy for six years in a high-complexity hospital in Colombia. Patients and Method: Cross-sectional descriptive study of patients aged < 18 years who received lock therapy. Collected variables included demographic data, clinical characteristics, blood test results, therapeutic interventions, frequency of admission to the pediatric critical care unit, and mortality. Descriptive analysis was performed. Results: 54 patients were included in the study, most of them males, with 67 episodes of therapeutic lock therapy use. The most frequent diagnosis was hematologi-cal neoplasm (61%). Among these patients, 88% presented neutropenia while receiving lock therapy. Catheter preservation was achieved in 75% of the cases. Aminoglycosides were the most commonly used antibiotics (38%). Mortality due to catheter-related bacteremia was 6%. Catheter preservation using ethanol solution 70% was achieved in 62% of the patients with prophylactic lock therapy, all of whom had chronic gastrointestinal pathology. Conclusion: Catheter preservation rates were 75% and 62% in patients with therapeutic and prophylactic lock therapy, respectively, with a higher rate achieved among cancer patients with neutropenia (80%). Aminoglycosides and vancomycin were the most commonly used antibiotics.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 50 条
  • [1] A Local Experience of Antibiotic Lock Therapy as an Adjunctive Treatment for Central Venous Catheter-Related Bloodstream Infections in Pediatric Oncology and Hematology Patients
    de Frutos Porras, Elena
    Cobo-Vazquez, Elvira
    Lobo, Alicia Hernanz
    del Mar Santos Sebastian, Maria
    Fernandez, Elia Perez
    Colino, Carmen Garrido
    Cela, Elena
    Gomez, Maria Luisa Navarro
    CHILDREN-BASEL, 2024, 11 (08):
  • [2] Central venous catheter-associated complications in pediatric patients diagnosed with Hodgkin lymphoma: implications for catheter choice
    van den Bosch, Ceder H.
    Spijkerman, Judith
    Wijnen, Marc H. W. A.
    Hovinga, Idske C. L. Kremer
    Meyer-Wentrup, Friederike A. G.
    van der Steeg, Alida F. W.
    van de Wetering, Marianne D.
    Fiocco, Marta
    Morsing, Indra E.
    Beishuizen, Auke
    SUPPORTIVE CARE IN CANCER, 2022, 30 (10) : 8069 - 8079
  • [3] Lock Therapy for Treatment and Prevention of Catheter-related Infections
    Shan, Adriana
    Santos-Sebastian, Mar
    Saavedra-Lozano, Jesus
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (10) : e358 - e362
  • [4] Antibiotic lock therapy for salvage of tunneled central venous catheters with catheter colonization and catheter-related bloodstream infection
    Zanwar, Saurabh
    Jain, Punit
    Gokarn, Anant
    Devadas, Santhosh Kumar
    Punatar, Sachin
    Khurana, Sachin
    Bonda, Avinash
    Pruthy, Ritesh
    Bhat, Vivek
    Qureshi, Sajid
    Khattry, Navin
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (01)
  • [5] Administration of 4% tetrasodium EDTA lock solution and central venous catheter complications in high-risk pediatric patients with intestinal failure: A retrospective cohort study
    Hirsch, Thomas I.
    Fligor, Scott C.
    Tsikis, Savas T.
    Mitchell, Paul D.
    DeVietro, Angela
    Carbeau, Sarah
    Wang, Sarah Z.
    McClelland, Jennifer
    Carey, Alexandra N.
    Gura, Kathleen M.
    Puder, Mark
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2024, 48 (05) : 624 - 632
  • [6] Experience of Peripherally Inserted Central Venous Catheter in Patients with Hematologic Diseases
    Hashimoto, Yoshinori
    Fukuta, Takanori
    Maruyama, Junko
    Omura, Hiromi
    Tanaka, Takayuki
    INTERNAL MEDICINE, 2017, 56 (04) : 389 - 393
  • [7] Central venous catheter safety in pediatric patients with intestinal failure
    Smith, Rachel Warsco
    Pettini, Melissa
    Gulden, Rachel
    Wendel, Danielle
    NUTRITION IN CLINICAL PRACTICE, 2023, 38 (06) : 1273 - 1281
  • [8] A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients
    Chaftari, Anne-Marie
    Hachem, Ray
    Szvalb, Ariel
    Taremi, Mahnaz
    Granwehr, Bruno
    Viola, George Michael
    Sapna, Amin
    Assaf, Andrew
    Numan, Yazan
    Shah, Pankil
    Gasitashvili, Ketevan
    Natividad, Elizabeth
    Jiang, Ying
    Slack, Rebecca
    Reitzel, Ruth
    Rosenblatt, Joel
    Mouhayar, Elie
    Raad, Issam
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (07)
  • [9] Use of Meropenem and Other Antimicrobial Lock Therapy in the Treatment of Catheter-Related Blood Stream Infections in Neonates: A Retrospective Study
    Piersigilli, Fiammetta
    Auriti, Cinzia
    Dotta, Andrea
    Goffredo, Bianca Maria
    Cairoli, Sara
    Savarese, Immacolata
    Campi, Francesca
    Corsetti, Tiziana
    Bersani, Iliana
    CHILDREN-BASEL, 2022, 9 (05):
  • [10] Antibiotic lock therapy for the treatment of peripherally inserted central venous catheter-related bloodstream infection in patients with hematological malignancies: a single center retrospective study
    Zhang, Qin
    Huo, Yujia
    Li, Chengfei
    Sun, Qinggang
    Xi, Xi
    Sun, Rui
    Sun, Qingju
    Jiang, Meijuan
    Li, Guang
    ANNALS OF HEMATOLOGY, 2025, : 1975 - 1984